Super Speciosa Review

If you are going to buy anyway

• •Confirm kratom is legal in your state and municipality before ordering
• •Tell your prescriber, especially if you take a GLP-1, an antidepressant, an opioid or a sedative
• •Choose powder, capsules or tea over extracts and shots — the dose curve is far less steep
• •Scan the QR code and read the batch report before your first dose
• •Do not use daily — dependence follows regular use and withdrawal is real
• •Never combine with alcohol, opioids or benzodiazepines
• •If you buy the gummies, store them where children and pets cannot reach them

What is 7-OH, and why does it matter that Super Speciosa refuses to sell it?

This is the most important thing on this page, and it is genuinely to the company's credit. 7-hydroxymitragynine (7-OH) is a minor kratom alkaloid that is far more potent at the opioid receptor than mitragynine, the main one. In recent years a market emerged in products concentrated or enriched in 7-OH, sold as kratom but pharmacologically very different from leaf. Regulators moved: federal agents seized roughly 73,000 units of 7-OH products in December 2025, and on 1 July 2026 the DEA issued a notice of intent to temporarily place 7-OH and three related substances into Schedule I. Super Speciosa publishes a position saying it has not and will not sell 7-OH products mislabelled as kratom, with co-founder Ken Loricchio quoted as saying there is not enough safety data to support it and that the science he has seen is concerning. Its own extracts report 30–60mg of mitragynine per serving with 7-OH at unquantifiable levels — the profile of natural leaf rather than an enriched product. In a category where plenty of vendors sell concentrated 7-OH and do not break the figure out on the label, taking a public position against it is the strongest quality signal a kratom brand can offer.

Is Super Speciosa certified by the American Kratom Association?

We could not confirm that it is, and this is worth flagging carefully because a lot of articles say otherwise. Numerous third-party pieces describe Super Speciosa as AKA GMP qualified or 'accredited by the American Kratom Association'. We checked the AKA's own published GMP Qualified Vendor list on 7 August 2026 and did not find Super Speciosa on it. Notably, the company's own site refers to a 'GMP-qualified facility' rather than explicitly claiming AKA certification in the material we reviewed — so the over-claim may be coming from third-party writers rather than from the brand. Those are different things: AKA GMP Qualified status requires an annual independent third-party audit against the association's standards, while a general reference to GMP practice does not. If AKA status matters to you, check the AKA list yourself and ask the company directly rather than relying on review articles.

Does kratom help with weight loss?

No. There is no meaningful clinical evidence that kratom causes weight loss, and Super Speciosa does not market it that way. Some users report reduced appetite, which is a common effect of opioid-receptor agonists generally, but that is a side effect of a substance with real dependence potential rather than a weight-management strategy. If you arrived here from a weight-loss search, everything else reviewed on this site is better suited to that goal. We review this brand because it appears in our affiliate programme, not because it belongs in a weight plan.

What are the real risks of kratom?

They are the same regardless of how good the vendor is, and they are worth stating plainly. The FDA advises consumers not to use kratom, citing liver toxicity, seizures, substance use disorder and death. Its principal alkaloids act on opioid receptors, producing sedation, nausea, vomiting, constipation, tolerance with escalating doses, physical dependence and withdrawal on stopping; at high doses or combined with other depressants, respiratory depression is possible. The CDC identified 91 kratom-involved overdose deaths in the US between July 2016 and December 2017 across 27 states, though other drugs were usually present. More recently, in late March 2026 the CDC reported that kratom-involved poisonings and hospitalisations had risen by more than 1,200% over the previous decade. None of that is specific to Super Speciosa. It is the substance.

Can I take kratom while I am on a GLP-1?

Not without asking your prescriber first, and there is a specific mechanical reason. Kratom's alkaloids are opioid-receptor agonists, and constipation is one of the most reliable consequences of opioid-receptor activity — the same mechanism that makes prescription opioids notorious for it. GLP-1 medications independently slow gastric emptying and commonly cause constipation. Taking both stacks the same problem twice, and severe constipation is already one of the more common reasons people stop GLP-1 treatment. There is a second issue: both cause nausea, vomiting and abdominal discomfort, so a kratom side effect can look exactly like a GLP-1 side effect — and on a GLP-1, persistent severe abdominal pain can signal pancreatitis or gallbladder disease and needs proper attention rather than being dismissed.

Is it legal where I live?

It depends. Kratom is not federally scheduled, but the FDA treats it as an unapproved botanical drug and maintains import alerts allowing it to detain shipments at the border. Eight states ban it outright as of July 2026: Alabama, Arkansas, Indiana, Louisiana, Vermont, Wisconsin, Connecticut and Tennessee. A number of counties and municipalities restrict it separately, and customers of this brand specifically mention state and municipal restrictions affecting their orders. Separately, the DEA's July 2026 notice of intent regarding 7-OH targets concentrated and semi-synthetic 7-OH products rather than the leaf — which is a change Super Speciosa's product policy already anticipates. Confirm your own state and local law before ordering; that responsibility is yours.

How good is the lab testing?

Better than most of the category. Super Speciosa publishes lab results and puts QR codes on packaging so you can pull up the report for what you are holding, and — more meaningfully — it quantifies alkaloids specifically, reporting mitragynine per serving and 7-OH content rather than a single opaque 'total extract' milligram figure. That specificity is the difference between a lab report you can act on and one that is decorative. One caveat on wording: the company describes its Florida facility as FDA-registered. Facility registration is an administrative listing, not an FDA inspection outcome, approval or endorsement, and a product made in a registered facility has no special regulatory standing. Read the batch report, not the badge.

Who should absolutely not use kratom?

Anyone pregnant, trying to conceive or breastfeeding — neonatal withdrawal has been reported in infants born to mothers who used kratom. Anyone with liver disease, given documented reports of kratom-associated liver injury. Anyone with a seizure disorder. Anyone taking opioids, benzodiazepines, alcohol or other central nervous system depressants, because of additive respiratory depression. Anyone with a history of substance use disorder, since kratom produces genuine physical dependence. Anyone under 18, or 21 depending on jurisdiction. And if you take prescription medication generally, check interactions first — kratom alkaloids are handled by liver enzymes that process a great many other drugs. This page is information, not medical advice.